|
| 19/12/2003 |
ALIZYME GRANTED CTX FOR PHASE IIa CLINICAL TRIAL FOR ATL-104 FOR MUCOSITIS |
|
| 22/10/2003 |
INSTITUTIONAL PLACING RAISES £11.5 MILLION |
|
| 09/10/2003 |
ALIZYME ANNOUNCES GRANT OF USA PATENT FOR ATL-962 FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS |
|
| 24/09/2003 |
ALIZYME ANNOUNCES SUCCESSFUL PRELIMINARY RESULTS OF ITS PHASE IIb CLINICAL TRIAL OF RENZAPRIDE IN MIXED-SYMPTOM IBS AND AN UPDATE OF THE RENZAPRIDE IBS DEVELOPMENT PROGRAMME |
|
| 19/09/2003 |
ALIZYME ANNOUNCES SUCCESSFUL PRELIMINARY RESULTS FROM ITS PHASE IIb OBESITY CLINICAL TRIAL |
|
| 08/08/2003 |
ALIZYME GRANTS RIGHTS TO TAKEDA TO LICENSE AND DEVELOP |
|
| 08/08/2003 |
INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2003 |
|
| 09/05/2003 |
THE ANNUAL GENERAL MEETING : 2003 |
|
| 24/04/2003 |
ALIZYME ANNOUNCES PRELIMINARY RESULTS OF SUCCESSFUL PHASE IIb CLINICAL TRIAL OF RENZAPRIDE IN IRRITABLE BOWEL SYNDROME |
|
| 03/04/2003 |
FINANCIAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2002 |
|
| 19/03/2003 |
ALIZYME COMPLETES PATIENT RECRUITMENT IN PHASE IIb CLINICAL TRIAL OF RENZAPRIDE IN IRRITABLE BOWEL SYNDROME |
|
| 14/03/2003 |
PRELIMINARY RESULTS NOTIFICATION |
|
| 06/03/2003 |
ALIZYME COMPLETES PATIENT RECRUITMENT FOR ITS PHASE IIb OBESITY TRIAL |
|
| 26/02/2003 |
DIRECTOR'S SHARE PURCHASES |
|
| 20/02/2003 |
DIRECTORS' SHARE PURCHASES |
|
| 19/02/2003 |
ALIZYME PLC RESULTS OF PLACING AND OPEN OFFER AND EGM |
|
| 28/01/2003 |
ALIZYME PLC FULLY UNDERWRITTEN PLACING AND OPEN OFFER TO RAISE £16.1 MILLION |
|
Help